These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33193702)

  • 1. Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer.
    Wu M; Hu W; Wang G; Yao Y; Yu XF
    Front Genet; 2020; 11():580299. PubMed ID: 33193702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide N-Methyltransferase (NNMT) is Involved in Gastric Adenocarcinoma Immune Infiltration by Driving Amino Acid Metabolism.
    Lu J; Gui W; Tang S; Shi Q; Wang X; Huang L; Shen Y; Yang S; Xiang J; Yuan J; Mo J; Kong X; Huang M; Li X; Lu C
    Nutr Cancer; 2024; 76(8):745-759. PubMed ID: 38855943
    [No Abstract]   [Full Text] [Related]  

  • 3. Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma.
    Zhang L; Song M; Zhang F; Yuan H; Chang W; Yu G; Niu Y
    J Histochem Cytochem; 2021 Mar; 69(3):165-176. PubMed ID: 33283625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 5. NNMT Is an Immune-Related Prognostic Biomarker That Modulates the Tumor Microenvironment in Pan-Cancer.
    Liu W; Zhu M; Li X; Er L; Li S
    Dis Markers; 2023; 2023():9226712. PubMed ID: 36817086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatic analysis of cancer-associated fibroblast related gene signature as a predictive model in clinical outcomes and immune characteristics of gastric cancer.
    Zhang J; Zhang N; Fu X; Wang W; Liu H; McKay MJ; Dejkriengkraikul P; Nie Y
    Ann Transl Med; 2022 Jun; 10(12):698. PubMed ID: 35845527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide N-methyltransferase: a potential biomarker for worse prognosis in gastric carcinoma.
    Chen C; Wang X; Huang X; Yong H; Shen J; Tang Q; Zhu J; Ni J; Feng Z
    Am J Cancer Res; 2016; 6(3):649-63. PubMed ID: 27152242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic pan-cancer analysis of the nicotinamide n-methyltransferase in human cancer.
    Cao L; Wu W; Deng X; Peng Y; Chen Y; Guo H; Wang L; Li X; Zhang Z; Shao Z
    Front Genet; 2022; 13():1000515. PubMed ID: 36386816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization.
    Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J
    Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Gastric Cancer Stem Cell (GCSC) Markers Are Prognostic Factors Correlated With Immune Infiltration of Gastric Cancer.
    Lin T; Peng W; Mai P; Zhang E; Peng L
    Front Mol Biosci; 2021; 8():626966. PubMed ID: 34113647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
    Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL
    Front Genet; 2020; 11():810. PubMed ID: 33014010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinamide N-methyltransferase enhances the progression of prostate cancer by stabilizing sirtuin 1.
    You Z; Liu Y; Liu X
    Oncol Lett; 2018 Jun; 15(6):9195-9201. PubMed ID: 29805651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4 is a Novel Biomarker Correlated With Malignant Transformation and Immune Infiltrates in Gastric Precancerous Lesions.
    Jiang X; Zheng J; Liu L; Jiang K; Wen Y; Yan Y; Liu Y; Zhong L; Huang Y; Yao Z; Nie K; Zheng Z; Pan J; Liu P; Zhuang K; Liu F; Xu S; Li P
    Front Mol Biosci; 2021; 8():697993. PubMed ID: 34676245
    [No Abstract]   [Full Text] [Related]  

  • 14. Pan-cancer analysis combined with experiments predicts NNMT as a therapeutic target for human cancers.
    Huang H; Su L; Zhang R; Wu D; Ding C; Chen C; Zhu G; Cao P; Li X; Li Y; Liu H; Chen J
    Discov Oncol; 2024 May; 15(1):196. PubMed ID: 38809277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Development of Subtypes with Poor Prognosis in Gastric Cancer Based on Both Hypoxia and Immune Cell Infiltration.
    Wang Y; Sun J; Yang Y; Zebaze Dongmo S; Qian Y; Wang Z
    Int J Gen Med; 2021; 14():9379-9399. PubMed ID: 34908867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Nicotinamide N-Methyltransferase Expression in Patients With Solid Tumors: A Systematic Review and Meta-Analysis.
    Li S; Qiao L; Yang Z; He C
    Front Physiol; 2018; 9():1407. PubMed ID: 30349486
    [No Abstract]   [Full Text] [Related]  

  • 17. Nicotinamide
    Holstein S; Venz S; Junker H; Walther R; Stope MB; Zimmermann U
    Anticancer Res; 2019 Oct; 39(10):5427-5436. PubMed ID: 31570437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of NNMT in Glioma Aggravates Tumor Cell Progression: An Emerging Therapeutic Target.
    Sun W; Zou Y; Cai Z; Huang J; Hong X; Liang Q; Jin W
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could microtubule inhibitors be the best choice of therapy in gastric cancer with high immune activity: mutant DYNC1H1 as a biomarker.
    Bai J; Yang B; Shi R; Shao X; Yang Y; Wang F; Xiao J; Qu X; Liu Y; Zhang Y; Li Z
    Aging (Albany NY); 2020 Nov; 12(24):25101-25119. PubMed ID: 33221769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma.
    Ganzetti G; Sartini D; Campanati A; Rubini C; Molinelli E; Brisigotti V; Cecati M; Pozzi V; Campagna R; Offidani A; Emanuelli M
    Melanoma Res; 2018 Apr; 28(2):82-88. PubMed ID: 29420365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.